The collaboration between the Government of Japan and the United Nations Development Programme (UNDP) is a strategic partnership to promote research and development, and to increase access to and delivery of health technologies used to address tuberculosis (TB), malaria and neglected tropical diseases (NTDs). This partnership adopts an innovative, dual-pronged approach in which the Global Health Innovative Technology (GHIT) Fund stimulates R&D, while the Access and Delivery Partnership (ADP) assists low-and middle- income countries (LMICs) to enhance capacities to access and deliver new health technologies.

ADP – a partnership between UNDP, the World Health Organization (WHO), the Special Programme for Research and Training in Tropical Diseases (TDR) and PATH – works with countries to ensure lifesaving medicines and other health technologies for TB, malaria and NTDs reach the people in need. ADP supports countries to strengthen and harmonize policies and systems, and build the capacities of key people and institutions to drive the necessary reforms – paving the way for sustainable, country-led progress toward universal health coverage.

The GHIT Fund focuses on investments in the discovery and development of health technologies (including medicines, diagnostics and vaccines) for tuberculosis, malaria, neglected tropical diseases and other diseases of poverty. The GHIT Fund supports partnerships and identifies opportunities for collaboration with Japanese organizations involved in the R&D of global health technologies.